Literature DB >> 7836904

Motifs and supermotifs for MHC class II binding peptides.

F Sinigaglia1, J Hammer.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7836904      PMCID: PMC2191889          DOI: 10.1084/jem.181.2.449

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


× No keyword cloud information.
  22 in total

1.  Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.

Authors:  A B Vogt; H Kropshofer; H Kalbacher; M Kalbus; H G Rammensee; J E Coligan; R Martin
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

2.  Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.

Authors:  K W Marshall; A F Liu; J Canales; B Perahia; B Jorgensen; R D Gantzos; B Aguilar; B Devaux; J B Rothbard
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

3.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

4.  Promiscuous and allele-specific anchors in HLA-DR-binding peptides.

Authors:  J Hammer; P Valsasnini; K Tolba; D Bolin; J Higelin; B Takacs; F Sinigaglia
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

5.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.

Authors:  L J Stern; J H Brown; T S Jardetzky; J C Gorga; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

Review 6.  Assembly, transport, and function of MHC class II molecules.

Authors:  P Cresswell
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.

Authors:  J Hammer; C Belunis; D Bolin; J Papadopoulos; R Walsky; J Higelin; W Danho; F Sinigaglia; Z A Nagy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning.

Authors:  J Hammer; E Bono; F Gallazzi; C Belunis; Z Nagy; F Sinigaglia
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

9.  The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy.

Authors:  P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

10.  Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.

Authors:  G Malcherek; V Gnau; G Jung; H G Rammensee; A Melms
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  7 in total

1.  Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population.

Authors:  John Sidney; Amiyah Steen; Carrie Moore; Sandy Ngo; Jolan Chung; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

2.  Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.

Authors:  John Sidney; Amiyah Steen; Carrie Moore; Sandy Ngo; Jolan Chung; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-02-05       Impact factor: 5.422

3.  Substitutions in a major histocompatibility complex class II-restricted human immunodeficiency virus type 1 gp120 epitope can affect CD4+ T-helper-cell function.

Authors:  C Lekutis; N L Letvin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

4.  MHCPred: A server for quantitative prediction of peptide-MHC binding.

Authors:  Pingping Guan; Irini A Doytchinova; Christianna Zygouri; Darren R Flower
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

5.  A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner.

Authors:  Volker Schellenberger; Chia-Wei Wang; Nathan C Geething; Benjamin J Spink; Andrew Campbell; Wayne To; Michael D Scholle; Yong Yin; Yi Yao; Oren Bogin; Jeffrey L Cleland; Joshua Silverman; Willem P C Stemmer
Journal:  Nat Biotechnol       Date:  2009-12       Impact factor: 54.908

6.  Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis.

Authors:  J E Haberer; A M Da-Cruz; L Soong; M P Oliveira-Neto; L Rivas; D McMahon-Pratt; S G Coutinho
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

7.  An insulin peptide that binds an alternative site in class II major histocompatibility complex.

Authors:  S M Tompkins; J C Moore; P E Jensen
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.